San Diego Cardiovascular Interventions (SDCI) Course 2018
In-Person Event
Jul 20 - 21, 2018
La Jolla, California, USA
OVERVIEW
San Diego Cardiovascular Interventions (SDCI) Course is organized by Gaffney Events and will be held from Jul 20 - 21, 2018 at Estancia La Jolla Hotel & Spa, La Jolla, California, United States of America.
The target audience for this medical event is designed to meet the needs of Interventional Cardiologists, Clinical Cardiologists, Internists, Residents and Fellows in Training. This CME Conference has been approved for a maximum of 13.5 AMA PRA Category 1 Credits.
Course Description:
It will focus on disseminating the knowledge and evidence-based data regarding novel and innovative therapeutic options for patients with high-risk and complex coronary, structural and peripheral vascular disease. The symposium will focus on the use of robotic PCI, atherectomy, use of intravascular imaging and physiology for optimal cardiovascular revascularization. New coronary CTO techniques and tools, indications for the use of adjunctive hemodynamic support during high-risk PCI, outcomes of TAVR, Percutaneous Mitral Valve Repair, PFO/ASD closure and left atrial appendage closure will be presented. Appropriate pharmacotherapy for cardiac interventions will be reviewed. Participants will observe live cases and hear from international experts. I hope that you will join me in sunny San Diego for the 4th Annual San Diego Cardiovascular Interventions Symposium!
Course Objectives are:
• Identify new techniques and technologies for CTO, bifurcation and left main PCI
• Identify the role of various lesion modifications/atherectomy techniques prior to coronary stenting
• Identify the utility of adjunctive hemodynamic support to facilitate complete coronary revascularization and high-risk PCI
• Identify the advantages and utility of robotic PCI
• Review the data and indications for percutaneous VADs in severe decompensated CHF and cardiogenic shock
• Review the contemporary data and indications for TAVR
• Identify the role of left atrial appendage closure and percutaneous mitral valve repair
• Identify optimal oral and intravenous antiplatelet therapy for PCI
• Review optimal utilization of FFR, IVUS, and OCT in reducing inappropriate PCI
• Identify appropriate patients and approaches for peripheral vascular interventions
Additional details will be posted as soon as they are available.
The target audience for this medical event is designed to meet the needs of Interventional Cardiologists, Clinical Cardiologists, Internists, Residents and Fellows in Training. This CME Conference has been approved for a maximum of 13.5 AMA PRA Category 1 Credits.
Course Description:
It will focus on disseminating the knowledge and evidence-based data regarding novel and innovative therapeutic options for patients with high-risk and complex coronary, structural and peripheral vascular disease. The symposium will focus on the use of robotic PCI, atherectomy, use of intravascular imaging and physiology for optimal cardiovascular revascularization. New coronary CTO techniques and tools, indications for the use of adjunctive hemodynamic support during high-risk PCI, outcomes of TAVR, Percutaneous Mitral Valve Repair, PFO/ASD closure and left atrial appendage closure will be presented. Appropriate pharmacotherapy for cardiac interventions will be reviewed. Participants will observe live cases and hear from international experts. I hope that you will join me in sunny San Diego for the 4th Annual San Diego Cardiovascular Interventions Symposium!
Course Objectives are:
• Identify new techniques and technologies for CTO, bifurcation and left main PCI
• Identify the role of various lesion modifications/atherectomy techniques prior to coronary stenting
• Identify the utility of adjunctive hemodynamic support to facilitate complete coronary revascularization and high-risk PCI
• Identify the advantages and utility of robotic PCI
• Review the data and indications for percutaneous VADs in severe decompensated CHF and cardiogenic shock
• Review the contemporary data and indications for TAVR
• Identify the role of left atrial appendage closure and percutaneous mitral valve repair
• Identify optimal oral and intravenous antiplatelet therapy for PCI
• Review optimal utilization of FFR, IVUS, and OCT in reducing inappropriate PCI
• Identify appropriate patients and approaches for peripheral vascular interventions
Additional details will be posted as soon as they are available.
KEY DATES
20 Jul, 2018
Event Start Date
21 Jul, 2018
Event End Date
SPECIALITIES
CardiologySUGGESTED HOTELS
CONFERENCE VENUE
Estancia La Jolla Hotel & SpaRELATED CONFERENCES & LIVE WEBINARS
Quick Links